chr15-51208741-A-C
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_000103.4(CYP19A1):c.*2067T>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0021 ( 0 hom., cov: 23)
Failed GnomAD Quality Control
Consequence
CYP19A1
NM_000103.4 3_prime_UTR
NM_000103.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.21
Publications
0 publications found
Genes affected
CYP19A1 (HGNC:2594): (cytochrome P450 family 19 subfamily A member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and catalyzes the last steps of estrogen biosynthesis. Mutations in this gene can result in either increased or decreased aromatase activity; the associated phenotypes suggest that estrogen functions both as a sex steroid hormone and in growth or differentiation. Alternative promoter use and alternative splicing results in multiple transcript variants that have different tissue specificities. [provided by RefSeq, Dec 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -4 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000103.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CYP19A1 | NM_000103.4 | MANE Select | c.*2067T>G | 3_prime_UTR | Exon 10 of 10 | NP_000094.2 | |||
| CYP19A1 | NM_001347248.1 | c.*2067T>G | 3_prime_UTR | Exon 10 of 10 | NP_001334177.1 | P11511-1 | |||
| CYP19A1 | NM_001347249.2 | c.*2067T>G | 3_prime_UTR | Exon 10 of 10 | NP_001334178.1 | P11511-1 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CYP19A1 | ENST00000396402.6 | TSL:1 MANE Select | c.*2067T>G | 3_prime_UTR | Exon 10 of 10 | ENSP00000379683.1 | P11511-1 | ||
| MIR4713HG | ENST00000559909.1 | TSL:4 | n.195-69242A>C | intron | N/A | ||||
| MIR4713HG | ENST00000805692.1 | n.279-69242A>C | intron | N/A |
Frequencies
GnomAD3 genomes AF: 0.00210 AC: 178AN: 84698Hom.: 0 Cov.: 23 show subpopulations
GnomAD3 genomes
AF:
AC:
178
AN:
84698
Hom.:
Cov.:
23
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AC0;AS_VQSRAC: 0AN: 0Hom.: 0 Cov.: 0AC XY: 0AN XY: 0
GnomAD4 exome
Data not reliable, filtered out with message: AC0;AS_VQSR
AC:
0
AN:
0
Hom.:
Cov.:
0
AC XY:
0
AN XY:
0
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.00210 AC: 178AN: 84736Hom.: 0 Cov.: 23 AF XY: 0.00190 AC XY: 78AN XY: 41026 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
178
AN:
84736
Hom.:
Cov.:
23
AF XY:
AC XY:
78
AN XY:
41026
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
39
AN:
21802
American (AMR)
AF:
AC:
12
AN:
7620
Ashkenazi Jewish (ASJ)
AF:
AC:
9
AN:
2154
East Asian (EAS)
AF:
AC:
8
AN:
2726
South Asian (SAS)
AF:
AC:
2
AN:
2418
European-Finnish (FIN)
AF:
AC:
3
AN:
4922
Middle Eastern (MID)
AF:
AC:
0
AN:
180
European-Non Finnish (NFE)
AF:
AC:
100
AN:
41264
Other (OTH)
AF:
AC:
3
AN:
1124
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.256
Heterozygous variant carriers
0
22
45
67
90
112
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
ClinVar submissions
View on ClinVar Significance:Uncertain significance
Revision:criteria provided, single submitter
Pathogenic
VUS
Benign
Condition
-
1
-
Aromatase deficiency (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.